Literature DB >> 2019152

Amikacin pharmacokinetics during continuous veno-venous hemofiltration.

R Robert, E Rochard, F Malin, S Bouquet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2019152     DOI： 10.1097/00003246-199104000-00029

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  4 in total

1.  Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.

Authors:  Claire Roger; Steven C Wallis; Laurent Muller; Gilbert Saissi; Jeffrey Lipman; Jean-Yves Lefrant; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 2.  Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.

Authors:  Michael A Veltri; Alicia M Neu; Barbara A Fivush; Rulan S Parekh; Susan L Furth
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

3.  Amikacin pharmacokinetics during continuous veno-venous hemodialysis.

Authors:  Simon W Lam; Seth R Bauer
Journal:  Infect Dis Ther       Date:  2013-08-16

4.  An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.

Authors:  Deirdre M D'Arcy; Eoin Casey; Caitriona M Gowing; Maria B Donnelly; Owen I Corrigan
Journal:  BMC Pharmacol Toxicol       Date:  2012-11-08       Impact factor: 2.483
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.